Chloe Gross - Concepedia

Concepedia

Author

Chloe Gross

University of Maryland, Baltimore

Also Known As

C. Gross, Chloe Gross

28

Publications

1.2K

Citations

14

H-Index

14

Concepts

All Affiliations

University of Maryland, Baltimore National Institute of Allergy and Infectious Diseases National Institutes of Health Gilead Sciences (United States)National Institutes of Health Clinical Center

CG

About

Chloe Gross is an author at University of Maryland, Baltimore specializing in medicine, viral hepatitis, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	383
2	Hepatology	3	3	360
3	Epidemiology	2	2	316
4	Public Health	1	1	165
5	Diabetes	1	1	44

Chloe Gross

×

15

Publications

1.2K

Citations

14

H-Index

	Year	Citations
Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers Sarah Kattakuzhy, Chloe Gross, Benjamin Emmanuel, Annals of Internal Medicine	2017	224
Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection Anu Osinusi, Kerry Townsend, Anita Kohli, JAMA	2015	203
Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study Anita Kohli, Rama Kapoor, Zayani Sims, The Lancet Infectious Diseases HepatologyHepatitis CViral HepatitisGenetic EpidemiologyAntiviral Therapy	2015	165
Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study Anita Kohli, A. Osinusi, Zayani Sims, The Lancet HepatologyHepatitis CWeek Triple-drug RegimensViral HepatitisHepatitis B	2015	151
Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs Elana Rosenthal, Rachel Silk, Poonam Mathur, Clinical Infectious Diseases	2020	121
High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study Tess Petersen, Kerry Townsend, Lori A. Gordon, Hepatology International	2015	66
Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection Anita Kohli, Sarah Kattakuzhy, Sreetha Sidharthan, Annals of Internal Medicine	2015	57
Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens Eleanor Wilson, Sarah Kattakuzhy, Sreetha Sidharthan, Clinical Infectious Diseases	2015	51
No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV Chloe S Chaudhury, Julia Sheehan, Cheryl Chairez, The Journal of Infectious Diseases Lipid DisorderHepatitis C ClearanceHepatologyHepatitis CViral Hepatitis	2017	44
Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti–Hepatitis C Virus Therapy in Patients With Advanced Liver Disease Sarah Kattakuzhy, Eleanor Wilson, Sreetha Sidharthan, Clinical Infectious Diseases	2015	33

Page 1